Elevated NfL levels in both pediatric and adult patients with CIS have been reported to be associated with a shorter time to clinically definite MS diagnosis independent of other prognostic factors (Van Der Vuurst De Vries et al., 2019). Here, NEFL is linked to myeloid sarcoma.